Differential Virulence Gene Expression of Group A Streptococcus Serotype M3 in Response to Co-Culture with Moraxella catarrhalis
暂无分享,去创建一个
[1] K. Riesbeck,et al. Genome Analysis of Moraxella catarrhalis Strain RH4, a Human Respiratory Tract Pathogen , 2012 .
[2] L. Drago,et al. Nasopharyngeal Biofilm-Producing Otopathogens in Children with Nonsevere Recurrent Acute Otitis Media , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[3] R. Olsen,et al. An amino‐terminal signal peptide of Vfr protein negatively influences RopB‐dependent SpeB expression and attenuates virulence in Streptococcus pyogenes , 2011, Molecular microbiology.
[4] M. Federle,et al. Two Group A Streptococcal Peptide Pheromones Act through Opposing Rgg Regulators to Control Biofilm Development , 2011, PLoS pathogens.
[5] Therése Nordström,et al. Moraxella catarrhalis Outer Membrane Vesicles Carry β-Lactamase and Promote Survival of Streptococcus pneumoniae and Haemophilus influenzae by Inactivating Amoxicillin , 2011, Antimicrobial Agents and Chemotherapy.
[6] J. Musser,et al. Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations , 2011, Proceedings of the National Academy of Sciences.
[7] A. Hofman,et al. Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae. , 2011, Microbiology.
[8] E. Garcia-Melchor,et al. Necrotizing fasciitis and myositis caused by streptococcal flesh-eating bacteria. , 2010, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[9] W. Swords,et al. Interspecies bacterial communication as a target for therapy in otitis media , 2010, Expert review of anti-infective therapy.
[10] V. Nizet,et al. M Protein and Hyaluronic Acid Capsule Are Essential for In Vivo Selection of covRS Mutations Characteristic of Invasive Serotype M1T1 Group A Streptococcus , 2010, mBio.
[11] C. Doern,et al. Loss of the Group A Streptococcus Regulator Srv Decreases Biofilm Formation In Vivo in an Otitis Media Model of Infection , 2010, Infection and Immunity.
[12] Richard A. Juneau,et al. Indirect Pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in Polymicrobial Otitis Media Occurs via Interspecies Quorum Signaling , 2010, mBio.
[13] A. Norrby-Teglund,et al. Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J. Musser,et al. Adaptation of Group A Streptococcus to Human Amniotic Fluid , 2010, PloS one.
[15] S. Esposito,et al. Insights into infectious otitis media. , 2010, International journal of immunopathology and pharmacology.
[16] Allan W Cripps,et al. Otitis media: viruses, bacteria, biofilms and vaccines , 2009, The Medical journal of Australia.
[17] A. S. Attia,et al. Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis , 2009, BMC Microbiology.
[18] J. Musser,et al. Transcriptome Adaptation of Group B Streptococcus to Growth in Human Amniotic Fluid , 2009, PloS one.
[19] L. Björck,et al. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant. , 2009, Bioorganic & medicinal chemistry.
[20] M. Pichichero,et al. Adherence of Streptococcus pyogenes to human epithelial cells is modulated by Haemophilus influenzae , 2009, Scandinavian journal of infectious diseases.
[21] A. Vergison. Microbiology of otitis media: A moving target , 2008, Vaccine.
[22] J. Musser,et al. Extensive Adaptive Changes Occur in the Transcriptome of Streptococcus agalactiae (Group B Streptococcus) in Response to Incubation with Human Blood , 2008, PloS one.
[23] U. von Pawel-Rammingen,et al. The streptococcal protease IdeS modulates bacterial IgGFc binding and generates 1/2Fc fragments with the ability to prime polymorphonuclear leucocytes. , 2008, Molecular immunology.
[24] J. Musser,et al. A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus , 2008, Proceedings of the National Academy of Sciences.
[25] T. Ross,et al. Effect of relative inoculum concentration on Listeria monocytogenes growth in co-culture. , 2008, International journal of food microbiology.
[26] M. Cunningham. Pathogenesis of group A streptococcal infections and their sequelae. , 2008, Advances in experimental medicine and biology.
[27] H. Gnehm,et al. Mastoiditis in children: a prospective, observational study comparing clinical presentation, microbiology, computed tomography, surgical findings and histology , 2008, European Journal of Pediatrics.
[28] D. Rasko,et al. Metabolic Analysis of Moraxella catarrhalis and the Effect of Selected In Vitro Growth Conditions on Global Gene Expression , 2007, Infection and Immunity.
[29] J. Musser,et al. Regulation of Polysaccharide Utilization Contributes to the Persistence of Group A Streptococcus in the Oropharynx , 2007, Infection and Immunity.
[30] M. Caparon,et al. Comparative functional analysis of the lac operons in Streptococcus pyogenes , 2007, Molecular microbiology.
[31] S. Sriskandan,et al. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. , 2007, The international journal of biochemistry & cell biology.
[32] J. Musser,et al. Expression Microarray and Mouse Virulence Analysis of Four Conserved Two-Component Gene Regulatory Systems in Group A Streptococcus , 2006, Infection and Immunity.
[33] Edward A Graviss,et al. Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease Specificity , 2006, PLoS pathogens.
[34] J. Musser,et al. Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. R. Lafontaine,et al. Moraxella catarrhalis Coaggregates with Streptococcus pyogenes and Modulates Interactions of S. pyogenes with Human Epithelial Cells , 2004, Infection and Immunity.
[36] J. Musser,et al. Group A Streptococcus Gene Expression in Humans and Cynomolgus Macaques with Acute Pharyngitis , 2003, Infection and Immunity.
[37] L. Björck,et al. IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. , 2003, Current opinion in microbiology.
[38] M. Wessels,et al. Cytotoxic Effects of Streptolysin O and Streptolysin S Enhance the Virulence of Poorly Encapsulated Group A Streptococci , 2003, Infection and Immunity.
[39] John D. Fraser,et al. The Bacterial Superantigen Streptococcal Mitogenic Exotoxin Z Is the Major Immunoactive Agent of Streptococcus pyogenes1 , 2002, The Journal of Immunology.
[40] Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. , 2001, Journal of bacteriology.
[41] B. Kreikemeyer,et al. Group A streptococcal growth phase‐associated virulence factor regulation by a novel operon (Fas) with homologies to two‐component‐type regulators requires a small RNA molecule , 2001, Molecular microbiology.
[42] M. Cunningham,et al. Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.
[43] B. Carpentier,et al. Limitation of adhesion and growth of Listeria monocytogenes on stainless steel surfaces by Staphylococcus sciuri biofilms , 2000, Journal of applied microbiology.
[44] P. Bremer,et al. Survival of Streptococcus pyogenes under stress and starvation. , 1999, FEMS microbiology letters.
[45] J. Struthers,et al. Interaction of Streptococcus pneumoniae andMoraxella catarrhalis: Investigation of the Indirect Pathogenic Role of β-Lactamase-Producing Moraxellae by Use of a Continuous-Culture Biofilm System , 1998, Antimicrobial Agents and Chemotherapy.
[46] W. Traub,et al. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. , 1997, Chemotherapy.
[47] J. Verhoef,et al. Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. , 1994, The Journal of infectious diseases.
[48] G. Doern. Branhamella catarrhalis: phenotypic characteristics. , 1990, The American journal of medicine.
[49] J. Alouf,et al. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). , 1980, Pharmacology & therapeutics.